High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK

The emerging NDM carbapenemases

(2011) Patrice Nordmann et al.   TRENDS IN MICROBIOLOGY

Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum  -Lactamases: a Prospective Study with Swedish Volunteers

(2010) T. Tangden et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High Prevalence of ST131 Isolates Producing CTX-M-15 and CTX-M-14 among Extended-Spectrum- -Lactamase-Producing Escherichia coli Isolates from Canada

(2010) G. Peirano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States

(2010) James R. Johnson et al.   CLINICAL INFECTIOUS DISEASES

Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact

(2010) Jesús Oteo et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Colonisation with Escherichia coli resistant to “critically important” antibiotics: a high risk for international travellers

(2010) K. Kennedy et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008

(2010) S. Hawser et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4

(2010) Gisele Peirano et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Regional survey of CTX-M-type extended-spectrum  -lactamases among Enterobacteriaceae reveals marked heterogeneity in the distribution of the ST131 clone

(2010) L. Xu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

(2010) Karthikeyan K Kumarasamy et al.   LANCET INFECTIOUS DISEASES

Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea

(2010) Johan Tham et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Molecular Characteristics of Extended-Spectrum- -Lactamase-Producing Escherichia coli Isolates Causing Bacteremia in the Calgary Health Region from 2000 to 2007: Emergence of Clone ST131 as a Cause of Community-Acquired Infections

(2009) J. D. D. Pitout et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The changing epidemiology of resistance

(2009) P. M. Hawkey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence and clonality of extended-spectrum β-lactamases in Asia

(2008) P.M. Hawkey   CLINICAL MICROBIOLOGY AND INFECTION

The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: a successful collaborative model

(2008) A. R. White et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

BSAC standardized disc susceptibility testing method (version 7)

(2008) J. M. Andrews et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

UK epidemic Escherichia coli strains A-E, with CTX-M-15  -lactamase, all belong to the international O25:H4-ST131 clone

(2008) S. H. Lau et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High Rate of Intestinal Colonization with Extended-Spectrum- -Lactamase-Producing Organisms in Household Contacts of Infected Community Patients

(2008) A. Valverde et al.   JOURNAL OF CLINICAL MICROBIOLOGY